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Abstract
Both tuberculosis cervical lymphadenitis (TCL) and oropharyngeal tularaemia (OT) have similar signs, symptoms and pathological ﬁndings.
We aimed to investigate the frequency of tularaemia antibodies in patients diagnosed with TCL. Using data from the Tuberculosis Control
Dispensaries between the years of 2008 and 2011 in Turkey, all patients diagnosed with TCL were informed about and included in the study.
Control group subjects were selected from healthy blood donors who lived in the same region. After informed consent was obtained, the
sera obtained from volunteer TCL patients and the control group were tested with a microagglutination technique for Francisella tularensis.
Antibodies to Brucella were also investigated with a tube agglutination test for cross-reactivity in sera that were seropositive for tularaemia.
Sera were obtained from a total of 1170 individuals in the TCL group and 596 in the control group from 67 of 81 provinces in Turkey.
Francisella tularensis-positive antibodies were found in 79 (6.75%) cases in the TCL group and two (0.33%) cases in the control group with a
titre of  1:80 (p < 0.01). When the presence of antibody of any titre was considered, the ratio became 8.2% (96/1170) in the TCL group
and 0.67% (4/596) in the control group (p < 0.001). For the ﬁrst time, with this study, tularaemia serology was found to be positive in a
signiﬁcant portion (6.75%) of diagnosed cases of TCL. In tularaemia endemic regions, it was concluded that tularaemia serology should be
investigated in patients suspected of having TCL.
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Introduction
Francisella tularensis can remain viable within macrophages [1].
Regional lymphadenopathy is one of the most typical ﬁndings
of tularaemia [2,3]. Francisella tularensis is transmitted by
environmental exposure and is also deﬁned as a potential
bioterrorism agent [4,5].
While ulceroglandular tularaemia is the most common
clinical form in a signiﬁcant part of the world, oropharyngeal
tularaemia (OT) is the most common clinical presentation in
Turkey [6]. OT generally presents with pharyngitis and
lymphadenopathy after consuming contaminated water and/
or food [7]. Cervical lymphadenopathy (CL) generally pro-
gresses to a pathology with granulomatous inﬂammation and/
or caseiﬁcation necrosis in many OT cases who are treated
with inappropriate antibiotics (e.g. beta-lactams) [8,9].
Tuberculosis is an important public health problem in
Turkey and throughout the world [10,11].Tuberculosis may be
present as extrapulmonary tuberculosis [12,13]. In Turkey,
approximately 1600–2000 tuberculosis lymphadenitis cases are
detected annually [14]. Tuberculosis cervical lymphadenopathy
(TCL) and some bacterial diseases (such as cat scratch disease,
actinomycosis, non-tuberculosis mycobacterial diseases, etc.)
may cause suppurative lymphadenopathy. OT has very similar
ﬁndings as well. Both have symptoms and ﬁndings such as
fever, chills and CL and granulomatous inﬂammation in biopsy
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specimens. Our hypothesis is that OT may be misdiagnosed as
TCL in tularaemia endemic areas [15,16]. To our knowledge,
there is no study in the English literature concerning tulara-
emia prevalence in patients diagnosed with TCL. For the ﬁrst
time with this study, we aimed to investigate the frequency of
tularaemia antibodies in patients diagnosed with TCL.
Methods
This study was planned by the Tularaemia Study Group of the
Turkish Microbiology Society and was supported by the
Turkish Ministry of Health.
Approvals
This study has been approved by the local ethics board (Ethics
Board of Duzce University, Turkey). Institutional approvals
were obtained from the Turkish Ministry of Health.
Cases
In Turkey, there were 229 tuberculosis control dispensaries.
For this study, all of the recorded cases who were followed
and treated as extrathoracic tuberculosis lymphadenitis (ETTL)
were invited into the study. Of voluntary patients with TCL,
1170 were included in this study.
In Turkey, most TCL cases were diagnosed on clinical and/
or pathological ﬁndings without deﬁnite microbiological diag-
nostic conﬁrmation. So some patients were probably infected
with F. tularensis rather than M. tuberculosis.
Control group
Healthy blood donors living in the patient regions were
selected as a control group according to suitable age and sex.
The case–control ratio was intended to be 1:1. Each member
of the control group was informed about the purpose of the
study. Their blood was taken after informed consent.
Samples
Blood samples were taken from cases living in 67 out of 81
cities in Turkey. All of the sera were transported to the Reﬁk
Saydam Hıfzıssıhha Institute (Ankara, Turkey) under appropri-
ate conditions. Sera were stored at 80°C until the study day.
Tests
Speciﬁc agglutinins to F. tularensis were investigated by micro-
agglutination tests using the F. tularensis LVS (NCTC 10857)
strain in the Department of National Tularemia Diagnosis
Reference Laboratory of the Reﬁk Saydam Hifzissihha Institute.
Two-fold dilutions of patient sera were prepared in U base
plates from 1/10 to 1/1280 titre and ﬁnal dilutions were
obtained with the addition of antigen in an equal volume. A
 1/80 titre was accepted as signiﬁcant. All microagglutination
positive sera obtained from subjects were also examined by
serial dilution (from 1:10 to 1:1280) using Brucella antigen.
Brucella antibodies showing cross-reactivity with F. tularensis
were investigated with Brucella tube agglutination tests.
Recall of seropositive cases
Seropositive patients were phoned and recalled for investiga-
tion of epidemiological and clinical features of tularaemia. Data
such as drinking water characteristics environmental exposure
(contact with hunting animals or ticks, etc.) and clinical ﬁndings
(fever, sore throat or swallowing difﬁculty) were recorded for
the patients who responded to this call (Table 1).
Statistical analysis
Statistical analysis was conducted using SPSS, 15.0 (SPSS,
Chicago, IL, USA). The data of the patients were grouped. The
Mann–Whitney U-test was used to compare continuous
variables; qualitative variables were compared using the chi-
square test and Fisher’s exact tests. A p value < 0.05 was
accepted as signiﬁcant.
Results
Demographic data
A total of 1170 patients with TCL and 596 control group
subjects from 67 cities in Turkey were included in the study.
TABLE 1. Demographic and clinical properties of tularaemia
agglutination positive cases
Risk factors Query
Yes
n %
No
n %
Epidemiological Living in rural areas 38 (63) 22 (37)
History of cattle feed? 36 (60) 24 (40)
Hunting 12 (20) 48 (80)
Contact with stream of water wells 11 (18) 49 (82)
Is drinking water chlorinated? 38 (63) 22 (37)
Contact with lake water? 13 (22) 47 (78)
An increase in the population of
mice in their habitat
33 (55) 27 (45)
Clinical Sore throat 27 (45) 33 (55)
Fever 31 (52) 29 (48)
Lymphadenomegaly 60 (100)
Single lymphadenomegaly 15 (25)
Lymphadenomegaly no more than
two places
8 (13)
Lymphadenomegaly with
more than two places
9 (15)
No information about lymphadenomegaly 28 (46)
Cough 15 (25) 45 (75)
Haemoptysis 5 (8) 55 (92)
Lung tuberculosis history 3 (5) 57 (95)
Tuberculosis in the family 8 (13) 52 (87)
Lymphadenomegaly in family members 3 (5) 57 (95)
Pharyngitis 60 (100) 0 (0)
Lesion in the mouth 12 (20) 48 (80)
Conjunctivitis 14 (23) 46 (77)
Rash 8 (13) 52 (87)
Splenomegaly 4 (7) 56 (93)
Hepatomegaly 4 (7) 56 (93)
Suppuration 20 (33) 40 (77)
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The median age of the TCL subjects was 44.1 years ( 19.2),
and 847 (72.4%) of them were female. Examination of at least
1170 control group subjects was planned within the scope of
the study. However, only 596 control subjects, 280 (47%) male
and 316 (53%) female), were included. The average age of
control group subjects was 39.2 years ( 17.1).
Tularaemia seropositivities
Signiﬁcant titres for tularaemia antibody seropositivity were
detected in 79 of the patients (6.75%) while two subjects of
the control group were found to be positive for signiﬁcant
antibody titres (p < 0.01) (Table 2). The seropositivity rate
increased up to a level of 8.2% (96/1170) for the study group
when positivities at lower titres were added. The median age
of the tularaemia seropositive subjects was 41.2 years
( 19.1) and 50 of them (63.3%) were female. Francisella
tularensis-positive antibodies were found in two subjects
(0.33%) in the control group with a titre of  1:80
(p < 0.01).
Use of diagnostic tests in patients with TCL
We also investigated from the archives how to diagnose TCL
in the 1170 patients. Histopathological examinations were
used for 926 patients (79.1%) and 190 of them were also
tested by mycobacteriological methods (acid fast staining and/
or culture), in addition to histopathological examination. A
total of 24 patients were tested only with mycobacteriological
methods, while neither histopathological examination nor
mycobacteriological methods were used for 220 patients. Of
1170 patients, 214 (18.2%) were tested by mycobacteriological
methods and 13 of them were positive for tularaemia
antibodies. Nine hundred and ﬁfty-six TCL (81.8%) patients
were diagnosed by clinical and/or histopathological ﬁndings and
65 (6.9%) of them were positive for tularaemia agglutination
(Table 3).
Brucella serology results
Tularaemia seropositive subjects were investigated for Brucella
serology and only in two cases were signiﬁcant ( 1/160)
Brucella agglutination titres found.
Epidemiological and clinical characteristics of seropositive
patients
A total of 79 tularaemia seropositive patients were recalled to
the dispensaries where they lived. Feedback was obtained for
60 (76%) of 79 patients. Various epidemiological and clinical
data were recorded. The majority of the patients diagnosed
with tularaemia lived in rural areas and 37% of the patients
were using non-chlorinated water. Among the cases, 60%
were feeding cattle in a barn, and 52% had fever and pharyngitis
anamnesis (Table 1).
Data on tuberculosis and TCL in Turkey
According to ofﬁcial records of the years 2005–2009, the total
number of tuberculosis cases varied between 20535 and 17402
annually. Within the same period, while the rate of ETTL was
7.9% (1622 cases) in 2005, it progressively rose and reached a
level of 11.7% (2036 cases) in 2009 [14]. Similarly, while the
numbers of recorded tularaemia cases were 431 in 2005, this
increased to approximately 1500 in 2010.
Discussion
There are only a limited number of case reports indicating that
OT was misdiagnosed as TCL [17,18]. However, there is no
available study concerning the misdiagnosis rate in a wide-scale
case series. The fact that OT cases were highly misdiagnosed
as TCL (6.75%) has been reported for the ﬁrst time in this
study in the English literature.
Tularaemia has been known in Turkey since 1936. Four
tularaemia outbreaks occurred in Turkey up until 1988, and
77% of these cases were reported as OT [19,20]. The number
TABLE 2. Comparison of controls and cases
Parameters
TCL diagnosed group
N (%)
Controls
N (%) p
N (1766) 1170 596
Tularaemia positivity (any titre) 96 (8.2%) 4 (0.7%) < 0.001
Tularaemia positivity (>1/80) 79 (6.7%) 2 (0.3%) < 0.001
TCL, cervical tuberculosis lymphadenopathy.
TABLE 3. Using of diagnostic tests for clinically compatible
cases with tuberculosis cervical lymphadenopathy
Using of diagnostic tests
Tularaemia
seropositivity
TotalPositive Negative
Mycobacterial analysis (microscopy and/or culture)
Available 14 200 214
Not available 65 891 956
Microscopy (EZN staining)
Positive 2 56 58
Negative 12 143 155
Mycobacterial culture
Positive 0 2* 2a
Negative 0 0 0
Histopathological analysis
Available 65 861 926
Not available 14 230 244
Both mycobacterial and histopathological analysis
Available 13 177 190
Not available 13 207 220
*A case had culture positivity but EZN staining negativity and the other one had
only culture request but no EZN staining.
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of endemic regions with reported cases has increased in the
last 10 years and the disease has become widespread in all
regions of Turkey. The annual number of tularaemia cases
between 2005 and 2008 was approximately 166. This
increased to 428 in 2009 and exceeded 1500 in 2010 [21].
Tuberculosis lymphadenitis is the most frequently occurring
form of extrapulmonary tuberculosis [17]. It was reported that
tuberculosis is responsible for 43% of peripheral lymphadenitis
in developing countries [22]. Differential diagnosis of TCL is
difﬁcult. Similar clinical ﬁndings may be seen in TCL and OT. It
is not possible to distinguish the diseases with only clinical
signs because they have the same clinical symptoms. The most
common clinical ﬁndings in patients with TCL are neck mass,
fever, chills, malaise, weight loss and night sweats. History and
physical examination, radiological and laboratory evaluation,
PPD test and ﬁne needle aspiration biopsy are usually
insufﬁcient for the diagnosis [23]. Culture positivity of TCL
is diagnostic for 10–77% of cases [24]. In Turkey, histopath-
ological evaluation is the most important criterion for clinicians
to make the decision to initiate antituberculosis therapy due to
the diagnosis of tuberculosis lymphadenitis. When we consider
the increasing trend of both tularaemia and tuberculosis
lymphadenitis in recent years, probable misdiagnosis should be
kept in mind. We suggest that some tularaemia cases might be
diagnosed as tuberculosis lymphadenitis. Turhan et al. [25]
reported a great outbreak in our country in which all cases
were oropharyngeal tularaemia. They reported a frequency of
fever of 91% and of sore throat of 74%. They encountered
fever and malaise in all subjects. Lymph node suppuration was
seen in 1/3 of cases. Similarly, in this study, we encountered a
history of fever and pharyngitis in our tularaemia seropositive
cases of 60% and 100%, respectively. Whereas pharyngitis
complaints are not the usual complaints of TCL patients, we
detected it in all our tularaemia seropositive patients. A history
of haemoptysis was determined in only eight cases. We believe
this situation supports our hypothesis.
Granulomatous inﬂammation and caseiﬁcation necrosis are
the most common histopathological ﬁndings in biopsy speci-
mens of TCL cases. Many pathologists reported possible
tuberculosis lymphadenitis when they determined caseiﬁcation
necrosis and granulomatosis inﬂammation in lymphadenopathy
biopsy specimens. However, similar caseiﬁcation necrosis and
granulomatous inﬂammation are also seen in OT [26]. Clini-
cians and pathologists not experienced with tularaemia may
easily misdiagnose it as TCL in patients with CL and
granulomatous inﬂammation. Without bacteriological conﬁr-
mation, diagnostic errors are more likely. We think that if the
diagnosis is not conﬁrmed through mycobacteriological meth-
ods (Ehrlich Ziehl Nelson staining and Mycobacterium culture,
PCR, etc.), a tularaemia serology should be applied before
tuberculosis treatment is started for patients suspected of
having TCL in tularaemia endemic regions.
In this study, 63% of tularaemia seropositive cases were
female. Of the cases 46.6% were housewives according to
occupation. [27]. In our country, tularaemia is usually trans-
mitted by a water-borne route. In Turkey, housewives are
exposed to water contact during housework and land work in
rural areas [21].The vast majority of female OT patients may
frequently be in contact with non-chlorinated water. There
were histories of non-chlorinated drinking water in 37% of
tularaemia seropositive patients (Table 2).
This study has some limitations. Only 67 of 81 cities (83%)
could be included in our study. The control group remained
below the targeted number due to a wide geographical study
area and low rate of voluntary attendance. Further limitations
of the study are the low number of subjects and the high
number of women in the control group. Still, the large
numbers of cases and controls provide a signiﬁcant contribu-
tion to the literature on the subject.
In summary, tularaemia antibodies can be found in a
considerable proportion of cases diagnosed as TCL. In
addition, both tularaemia and tuberculosis can cause granu-
lomatous inﬂammation and caseiﬁcation necrosis in the lymph
nodes. We conclude that tularaemia serology should be tested
in patients suspected of having TCL in tularaemia endemic
regions.
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